SPORE PEPTIDOGLYCAN DEGRADATION IN BACILLUS ANTHRACIS

炭疽杆菌中孢子肽聚糖的降解

基本信息

  • 批准号:
    6873758
  • 负责人:
  • 金额:
    $ 24.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-01 至 2007-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The infectious agent in anthrax is the dormant B. anthracis spore, and establishment of infection requires germination and outgrowth of the spore. Degradation of the spore cortex peptidoglycan wall during germination is necessary to allow rehydration and resumption of metabolism in the spore core. Cortex lytic enzymes are present in an inactive form in the spore and are activated only in the presence of specific germinant molecules. Goals of the proposed studies are identification of the important B. anthracis cortex lytic enzymes, characterization of their activities, and understanding of the mechanisms for their activation. Structures of the peptidoglycan found in B. anthracis dormant and germinating spores will be determined in order to identify cortex lytic activities operating during germination. Genes predicted to encode cortex lytic enzymes, based upon sequence similarities, will be disrupted and changes in germination lytic activities in the mutant strains will be characterized. Cortex lytic enzymes will be extracted and purified from germinating B. anthracis spores. The enzymatic activities and identities of these proteins will be determined. A greater understanding of the process of spore cortex lysis will suggest possible methods for combating anthrax infection on two fronts. Identification of drugs or treatments that block cortex lysis will allow treatment of individuals exposed to spores to prevent establishment of infection. Identification of chemicals or treatments that activate cortex lysis, resulting in germination and rendering the spores susceptible to standard bactericidal agents, will allow easier decontamination of spore-contaminated sites and prevention of human exposure.
描述(由申请人提供):炭疽中的感染因子是休眠的B。炭疽孢子,并且感染的建立需要孢子的萌发和生长。孢子皮层肽聚糖壁在萌发过程中的降解是必要的,以允许孢子核心中的再水合和恢复代谢。皮层裂解酶以非活性形式存在于孢子中,并且仅在特定萌发分子存在下被激活。拟议研究的目标是确定重要的B。炭疽皮层裂解酶,其活动的特点,并了解其激活机制。在B中发现的肽聚糖的结构。测定炭疽菌休眠和萌发孢子,以鉴定在萌发过程中起作用的皮层裂解活性。基于序列相似性,预测编码皮层裂解酶的基因将被破坏,突变株中发芽裂解活性的变化将被表征。将从萌发的B中提取和纯化皮层裂解酶。炭疽孢子这些蛋白质的酶活性和身份将被确定。对孢子皮层裂解过程的更深入了解将为在两个方面对抗炭疽感染提出可能的方法。鉴定阻断皮层溶解的药物或治疗将允许治疗暴露于孢子的个体以防止感染的建立。确定激活皮层溶解的化学品或处理方法,导致萌发并使孢子对标准杀菌剂敏感,将使孢子污染部位更容易去污并防止人类接触。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID L POPHAM其他文献

DAVID L POPHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID L POPHAM', 18)}}的其他基金

Studies of Bacterial Endospore Germination
细菌内生孢子萌发的研究
  • 批准号:
    10669174
  • 财政年份:
    2020
  • 资助金额:
    $ 24.65万
  • 项目类别:
Studies of Bacterial Endospore Germination
细菌内孢子萌发的研究
  • 批准号:
    10247686
  • 财政年份:
    2020
  • 资助金额:
    $ 24.65万
  • 项目类别:
Studies of Bacterial Endospore Germination
细菌内孢子萌发的研究
  • 批准号:
    10032962
  • 财政年份:
    2020
  • 资助金额:
    $ 24.65万
  • 项目类别:
Studies of Bacterial Endospore Germination - Adminstrative Supplement
细菌内生孢子萌发的研究 - 管理补充剂
  • 批准号:
    10806359
  • 财政年份:
    2020
  • 资助金额:
    $ 24.65万
  • 项目类别:
Studies of Bacterial Endospore Germination
细菌内孢子萌发的研究
  • 批准号:
    10456207
  • 财政年份:
    2020
  • 资助金额:
    $ 24.65万
  • 项目类别:
Stabilization and regulation of a Bacillus anthracis spore lytic enzyme
炭疽芽孢杆菌孢子裂解酶的稳定和调节
  • 批准号:
    8623183
  • 财政年份:
    2013
  • 资助金额:
    $ 24.65万
  • 项目类别:
BACTERIAL STUDIES
细菌研究
  • 批准号:
    7355285
  • 财政年份:
    2006
  • 资助金额:
    $ 24.65万
  • 项目类别:
SPORE PEPTIDOGLYCAN DEGRADATION IN BACILLUS ANTHRACIS
炭疽杆菌中孢子肽聚糖的降解
  • 批准号:
    6766607
  • 财政年份:
    2004
  • 资助金额:
    $ 24.65万
  • 项目类别:
SPORE PEPTIDOGLYCAN SYNTHESIS IN BACILLUS SUBTILIS
枯草芽孢杆菌孢子肽聚糖的合成
  • 批准号:
    6345243
  • 财政年份:
    2000
  • 资助金额:
    $ 24.65万
  • 项目类别:
SPORE PEPTIDOGLYCAN SYNTHESIS IN BACILLUS SUBTILIS
枯草芽孢杆菌孢子肽聚糖的合成
  • 批准号:
    6478967
  • 财政年份:
    2000
  • 资助金额:
    $ 24.65万
  • 项目类别:

相似海外基金

Development of rapid detection method for drug-resistant bacteria in pulmonary MAC disease and search for new antibacterial agents
肺部MAC疾病耐药菌快速检测方法的建立及新型抗菌药物的寻找
  • 批准号:
    23K07930
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
  • 批准号:
    23K07918
  • 财政年份:
    2023
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ATP Synthase as an emerging target for the pre-clinical development of broad-spectrum antibacterial agents against drug-resistant bacterial infections
ATP 合酶作为针对耐药细菌感染的广谱抗菌药物临床前开发的新兴靶标
  • 批准号:
    472342
  • 财政年份:
    2022
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Operating Grants
Clinical application of a rapid assay for antibacterial susceptibility test of beta-lactams and carbapenems antibacterial agents using MALDI-TOF MS
MALDI-TOF MS快速测定β-内酰胺类和碳青霉烯类抗菌药物药敏试验的临床应用
  • 批准号:
    22K07406
  • 财政年份:
    2022
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tailored and uniform fibre-like micelles as antibacterial agents.
定制且均匀的纤维状胶束作为抗菌剂。
  • 批准号:
    569719-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
  • 批准号:
    531450-2018
  • 财政年份:
    2022
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
  • 批准号:
    521908-2018
  • 财政年份:
    2021
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
  • 批准号:
    531450-2018
  • 财政年份:
    2021
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
  • 批准号:
    521908-2018
  • 财政年份:
    2020
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents.
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体。
  • 批准号:
    531450-2018
  • 财政年份:
    2020
  • 资助金额:
    $ 24.65万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了